Taizhou Mabtech Pharmaceutical Co.,Ltd

Related records

Trials (18)

• A Clinical Trial Comparing the Efficacy and Safety of Anyouping® and Platinum-based Chemotherapy With or Without Enlituo® in Advanced Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
• CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer
• Comparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque Psoriasis
• Comparative Study of EnliTuo® Before and After Technology Change in Healthy Male Volunteers
• Compare the PK, Safety, and Immunogenicity of Process-Changed CMAB007 and Xolair in Healthy Adult Male Subjects
• Comparing Efficacy and Safety of Enlituo® Versus Erbitux® Plus FOLFOX in Locally Advanced/Metastatic Colorectal Cancer With RAS/BRAF Wild-type and MSS/pMMR Status.
• Pharmacokinetic, Safety and Immunogenicity Study of CMAB015 and Cosentyx in Healthy Volunteers
• Pharmacokinetic, Safety and Immunogenicity Study of CMAB809 and Herceptin in Healthy Volunteers
• Pharmacokinetic, Safety and Immunogenicity Study of New Process CMAB015 and Cosentyx in Healthy Volunteers
• Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
• Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors
• Study of CMAB807 Post-change in Manufacturing Site and Prolia in Healthy Volunteers
• Study of CMAB807X Pre- and Post-change in Manufacturing Site and Xgeva® in Healthy Volunteers
• Study of Pharmacokinetic, Safety, Immunogenicity and Efficacy of CMAB819 and Nivolumab in R/M HNSCC
• The Study of Infliximab (CMAB008 and Remicade) in Healthy Subjects to Compare the PK and Safety
• The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD and Safety
• The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD, Safety and Immunogenicity
• To Compare Efficacy and Safety of CMAB007 and Xolair® in Patients With Chronic Spontaneous Urticaria